These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19203536)

  • 1. Classical resistance mechanisms.
    Jäeger W
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):46-8. PubMed ID: 19203536
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
    Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
    ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
    Kowalski P; Surowiak P; Lage H
    Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.
    Burcu M; O'Loughlin KL; Ford LA; Baer MR
    Leukemia; 2008 Nov; 22(11):2110-5. PubMed ID: 18418409
    [No Abstract]   [Full Text] [Related]  

  • 9. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
    Coburger C; Wollmann J; Krug M; Baumert C; Seifert M; Molnár J; Lage H; Hilgeroth A
    Bioorg Med Chem; 2010 Jul; 18(14):4983-90. PubMed ID: 20598550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.
    Donnenberg VS; Donnenberg AD
    J Clin Pharmacol; 2005 Aug; 45(8):872-7. PubMed ID: 16027397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
    Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug distribution, resistance to cytostatics and disease pathogenesis: many roles of ABC proteins].
    Lehmann S; Rane A
    Lakartidningen; 2004 Jan; 101(4):282-7. PubMed ID: 14979001
    [No Abstract]   [Full Text] [Related]  

  • 17. [Up-to-date approaches to clinical estimate of phenotype of multiple drug resistance associated with function of ABC-transporters in human solid tumors].
    Bogush EA; Kirsanov VIu
    Antibiot Khimioter; 2006; 51(9-10):50-5. PubMed ID: 18030792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Pedersen JM; Matsson P; Bergström CA; Norinder U; Hoogstraate J; Artursson P
    J Med Chem; 2008 Jun; 51(11):3275-87. PubMed ID: 18457386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance.
    Hembruff SL; Laberge ML; Villeneuve DJ; Guo B; Veitch Z; Cecchetto M; Parissenti AM
    BMC Cancer; 2008 Nov; 8():318. PubMed ID: 18980695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
    Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
    Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.